On the other hand, p-IGF1R and p-ERK1/2, assessed by immunohistochemistry in metastatic tumors, demonstrated smaller stained areas in LLC-challenged CreERT2 mice (Fig. 4E). Here, MAPK3 is linked to metastatic neoplasm.